Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Chronic thromboembolic pulmonary hypertension \[CTEPH\] is caused by pulmonary emboli that have enlarged in pulmonary arteries and have become organized into the vessel wall. Many patients with CTEPH are treated with balloon pulmonary angioplasty \[BPA\] which mechanically opens the narrow pulmonary arteries. It is unclear how much downstream functional pulmonary capillary surface area \[FCSA\] is recovered during BPA. The investigators plan to measure FCSAIn CTEPH patients, before and after a session of BPA.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• All patients eligible for balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Locations
Other Locations
Canada
David Langleben
RECRUITING
Montreal
Contact Information
Primary
David Langleben, MD
david.langleben@mcgill.ca
5143407531
Backup
Lyda Lesenko, MD
llesenko@jgh.mcgill.ca
514-340-8222
Time Frame
Start Date: 2023-03-23
Estimated Completion Date: 2028-01-30
Participants
Target number of participants: 40
Treatments
Experimental: Pre and post BPA
Sponsors
Leads: Jewish General Hospital

This content was sourced from clinicaltrials.gov